PROF
Profound Medical Corp.
Key Financials
Revenue
$16.1M
↑ 50.7%
Operating Income
$-41254000
↓ 24.8%
Net Income
$-42570000
↓ 53.0%
Gross Profit
$11.4M
↑ 61.9%
EPS (Diluted)
$1.41
↑ 25.9%
Shareholders' Equity
$66.4M
↑ 10.0%
Total Liabilities
$11.0M
↑ 12.5%
Total Assets
$77.5M
↑ 10.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| EFFECT | 5/19/2026 | View on SEC |
| 8-K | 5/15/2026 | View on SEC |
| 8-K | 5/14/2026 | View on SEC |
| S-3 | 5/12/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| 8-K | 4/16/2026 | View on SEC |
| 8-K | 4/14/2026 | View on SEC |
| 8-K | 4/1/2026 | View on SEC |
| 8-K | 3/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PROF |
| Company Name | Profound Medical Corp. |
| CIK | 1628808 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | A6 |
| Phone | 647-476-1350 |